Frequency of diagnostically significant hepatitis B surface antigen mutants

Journal of Medical Virology

Volumn 79, Issue SUPPL. 1, 2007, Pages

  Kuhns, Mary C ^a   McNamara, Anne L ^a   Holzmayer, Vera ^a   Lou, Sheng C ^a   Busch, Michael P ^b  

^a ABBOTT DIAGNOSTICS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HBsAg immunoassays; HBsAg mutants; Hepatitis B virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ANTIGEN DETECTION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; EPITOPE MAPPING; GENETIC SCREENING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; SERODIAGNOSIS; UNITED STATES; VIRUS DIAGNOSIS; VIRUS MUTATION;

HEPATITIS B VIRUS;

EID: 34748859978     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20962     Document Type: Conference Paper

References (17)

1. Avellon A, Echevarria JM. 2006. Frequency of hepatitis B virus "a" determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24-36.
2. Bernvil SS, Andrews V, Kuhns MC, McNamara AL. 1997. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 18:49-53.
3. CDC. 1996. Prevention of perinatal hepatitis B through enhanced case management - Connecticut, 1994-95, and United States, 1994. MMWR 45:585-587.
4. Coleman PF, Chen Y-CJ, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24.
5. Gerlich WH. 2004. Diagnostic problems caused by HBsAg mutants - A consensus report of an expert meeting. Intervirology 47:310-313.
6. Gibb R, Nimmo GR, O'Loughlin P, Lowe P, Drummond D. 2007. Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. J Med Virol 79:351-355.
7. Gish RG, Gadano AC. 2006. Chronic hepatitis B: Current epidemiology in the Americas and implications for management. J Viral Hepatitis 13:787-798.
8. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. 2004. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: Implications for future HBV screening policy. Transfusion 44:1332-1339.
9. La'ulu SL, Roberts WL. 2006. The analytic sensitivity and mutant detection capability of 6 hepatitis B surface antigen assays. Am J Clin Path 125:748-751.
10. Lada O, Benhamou Y, Poynard T, Thibault V. 2006. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: Influence of "a" determinant variants. J Virol 80:2968-2975.
11. Lavanchy D. 2005. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34:S1-S3.
12. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW. 2006. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR 55:1-25.
13. Scheiblauer H, Soboll H, Nick S. 2006. Evaluaton of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 78:S66-S70.
14. Schochetman G, Kuhns MC. 2006. HIV variants and hepatitis B surface antigen mutants: Diagnostic challenges for immunoassays. J Med Virol 78:S3-S6.
15. Tabor E. 2006. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 78:S43-S47.
16. Weber B. 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78:S59-S65.
17. Zuckerman JN, Zuckerman AJ. 2003. Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75-78.